New: Introducing the Finviz Crypto Map

Learn More
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
MRKR - Marker Therapeutics Inc - Stock Price Chart
TickerMRKR [NASD]
CompanyMarker Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap19.23MEPS (ttm)-1.33
P/E-EPS this Y-32.35%
Forward P/E-EPS next Y-13.02%
PEG-EPS past 5Y23.96%
P/S3.37EPS next 5Y7.40%
P/B1.32EPS Q/Q-48.92%
Dividend-Sales Q/Q-71.94%
Insider Own30.21%Inst Own17.29%
Insider Trans0.00%Inst Trans-13.58%
Short Float1.55%EarningsMay 16/b
Analyst Recom1.00Target Price6.00
Avg Volume1.15M52W Range0.95 - 5.99
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ELMS STEVEDirectorDec 23 '24Buy3.2011,08535,472325,370Dec 26 04:01 PM
New Enterprise Associates 16, 10% OwnerDec 23 '24Buy3.20554,2501,773,6001,625,678Dec 23 04:40 PM
ASST - Asset Entities Inc - Stock Price Chart
TickerASST [NASD]
CompanyAsset Entities Inc
CountryUSA
IndustryInternet Content & Information
Market Cap75.00MEPS (ttm)-1.35
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S110.29EPS next 5Y-
P/B14.37EPS Q/Q74.22%
Dividend-Sales Q/Q36.77%
Insider Own11.00%Inst Own5.14%
Insider Trans-3.00%Inst Trans0.89%
Short Float24.17%Earnings-
Analyst Recom-Target Price-
Avg Volume16.65M52W Range0.34 - 13.42
Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gaubert MichaelExecutive ChairmanJun 04 '25Sale7.4430,000223,21520,567Jun 06 05:00 PM
Krueger MatthewCFO, Treasurer and SecretaryJun 04 '25Sale8.2326,400217,2665,000Jun 06 05:00 PM
Michael GaubertOfficerMay 29 '25Proposed Sale7.1430,000214,200May 29 04:48 PM
Matthew KruegerOfficerMay 29 '25Proposed Sale7.1426,400188,496May 29 04:46 PM
Kyle FairbanksOfficerMay 29 '25Proposed Sale7.1426,667190,402May 29 04:44 PM
INTJ - Intelligent Group Ltd - Stock Price Chart
TickerINTJ [NASD]
CompanyIntelligent Group Ltd
CountryHong Kong
IndustryConsulting Services
Market Cap18.50MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.12EPS next 5Y-
P/B2.23EPS Q/Q-270.53%
Dividend-Sales Q/Q-19.65%
Insider Own68.61%Inst Own0.19%
Insider Trans0.00%Inst Trans-19.60%
Short Float3.52%Earnings-
Analyst Recom-Target Price-
Avg Volume420.23K52W Range0.48 - 1.70
Intelligent Group Ltd. engages in the provision of financial public relations services. Its services include arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures. The company was founded by Wai Lau on July 5, 2018 and is headquartered in Hong Kong.
ARWR - Arrowhead Pharmaceuticals Inc - Stock Price Chart
TickerARWR [NASD, RUT]
CompanyArrowhead Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.31BEPS (ttm)-1.38
P/E-EPS this Y103.90%
Forward P/E-EPS next Y-1840.62%
PEG-EPS past 5Y-
P/S4.25EPS next 5Y9.33%
P/B3.39EPS Q/Q371.04%
Dividend-Sales Q/Q-
Insider Own16.58%Inst Own74.57%
Insider Trans-2.11%Inst Trans5.36%
Short Float10.95%EarningsMay 12/a
Analyst Recom1.67Target Price41.77
Avg Volume1.64M52W Range9.57 - 29.86
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Myszkowski Kenneth AllenOfficerJul 10 '25Proposed Sale19.0440,000761,709Jul 10 04:30 PM
Anzalone Christopher RichardChief Executive OfficerApr 11 '25Sale11.4950,800583,6923,921,255Apr 11 06:20 PM
Anzalone Christopher RichardChief Executive OfficerApr 10 '25Sale10.8750,000543,5003,972,055Apr 11 06:20 PM
Anzalone Christopher RichardChief Executive OfficerApr 09 '25Sale10.0740,322406,1454,022,055Apr 11 06:20 PM
Anzalone Christopher RichardOfficerApr 11 '25Proposed Sale11.4950,800583,751Apr 11 04:29 PM
BIRD - Allbirds Inc - Stock Price Chart
TickerBIRD [NASD]
CompanyAllbirds Inc
CountryUSA
IndustryApparel Retail
Market Cap86.73MEPS (ttm)-11.08
P/E-EPS this Y16.09%
Forward P/E-EPS next Y18.78%
PEG-EPS past 5Y-42.65%
P/S0.48EPS next 5Y30.53%
P/B1.04EPS Q/Q22.47%
Dividend-Sales Q/Q-18.34%
Insider Own38.44%Inst Own17.12%
Insider Trans-0.35%Inst Trans-0.98%
Short Float19.06%EarningsMay 08/a
Analyst Recom2.50Target Price9.50
Avg Volume64.98K52W Range3.93 - 18.33
Allbirds, Inc. is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. It offers Men's Shoes, Women's Shoes, Men's Apparel, Women's Apparel, Socks, and Gift Cards. The company was founded by Timothy Brown and Joseph Zev Zwillinger on May 6, 2015 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vernachio JosephChief Executive OfficerJun 03 '25Sale7.154,45031,81898,032Jun 05 04:45 PM
Mitchell AnnChief Financial OfficerJun 03 '25Sale7.122,14615,28080,686Jun 05 04:31 PM
Vernachio JosephOfficerJun 03 '25Proposed Sale7.154,45031,800Jun 03 04:26 PM
Mitchell AnnOfficerJun 03 '25Proposed Sale7.122,14615,273Jun 03 04:25 PM
Vernachio JosephChief Executive OfficerMar 03 '25Sale6.132,48315,22838,527Mar 04 06:00 PM
MIRA - Mira Pharmaceuticals Inc - Stock Price Chart
TickerMIRA [NASD]
CompanyMira Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - General
Market Cap31.30MEPS (ttm)-0.50
P/E-EPS this Y26.67%
Forward P/E-EPS next Y15.58%
PEG-EPS past 5Y-224.25%
P/S-EPS next 5Y-
P/B23.39EPS Q/Q-22.94%
Dividend-Sales Q/Q-
Insider Own25.79%Inst Own5.47%
Insider Trans0.00%Inst Trans-13.95%
Short Float1.81%EarningsMay 28
Analyst Recom3.00Target Price17.75
Avg Volume1.50M52W Range0.62 - 5.01
Jul-13-25 02:35PM Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Jul-11-25 08:00AM MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition (ACCESSWIRE) +6.67%
Jul-03-25 08:00AM MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks (ACCESSWIRE)
Jun-30-25 08:00AM MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving Using SKNY-1, a Drug Candidate Under Definitive Agreement for Acquisition (ACCESSWIRE)
07:20AM EXCLUSIVE: MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study (Benzinga)
Jun-25-25 08:00AM MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects (ACCESSWIRE)
Jun-18-25 08:30AM MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology (ACCESSWIRE)
May-28-25 08:30AM MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program (ACCESSWIRE) +6.35%
May-11-25 03:33PM Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
May-09-25 11:11AM Psychedelic: Compass, GH Research, MindMed report quarterly earnings (TipRanks)
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aminov ErezChief Executive OfficerNov 19 '24Sale1.3955,41077,0201,105,790Nov 27 04:15 PM
Aminov ErezChief Executive OfficerNov 20 '24Sale1.2744,59056,6291,061,200Nov 27 04:15 PM
Erez AminovAffiliateNov 19 '24Proposed Sale1.41100,000141,000Nov 19 05:58 PM
Brian McNultyaffiliateSep 04 '24Proposed Sale1.8010,00018,000Sep 04 08:20 PM
McNulty Brian Patrick10% OwnerAug 28 '24Sale1.96200,000392,0002,540,270Aug 30 04:05 PM
HBNB - Hotel101 Global Holdings Corp - Stock Price Chart
TickerHBNB [NASD]
CompanyHotel101 Global Holdings Corp
CountrySingapore
IndustryTravel Services
Market Cap508.11MEPS (ttm)0.27
P/E7.98EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.27EPS Q/Q25.99%
Dividend-Sales Q/Q-
Insider Own27.25%Inst Own1.75%
Insider Trans0.00%Inst Trans-
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume219.87K52W Range2.38 - 19.28
Jun-27-25 08:05PM HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER "HBNB" (PR Newswire) +13.35% -65.98%
Hotel101 Global Holdings Corp. engages in the development and sale of real estate and hotel units. The company was founded by Edgar J. Sia II and Tony Tan Caktiong on March 13, 2024 and is headquartered in Singapore.
HYPR - Hyperfine Inc - Stock Price Chart
TickerHYPR [NASD]
CompanyHyperfine Inc
CountryUSA
IndustryMedical Devices
Market Cap71.62MEPS (ttm)-0.55
P/E-EPS this Y16.68%
Forward P/E-EPS next Y10.47%
PEG-EPS past 5Y11.81%
P/S6.11EPS next 5Y12.13%
P/B1.66EPS Q/Q9.13%
Dividend-Sales Q/Q-35.14%
Insider Own25.97%Inst Own9.43%
Insider Trans-0.03%Inst Trans-9.78%
Short Float5.18%EarningsMay 13/a
Analyst Recom1.67Target Price1.06
Avg Volume2.29M52W Range0.53 - 1.90
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TEISSEYRE THOMASChief Operating OfficerMay 16 '25Sale0.582,7761,61082,213May 16 06:30 PM
TEISSEYRE THOMASChief Operating OfficerFeb 18 '25Sale1.203,2373,88484,990Feb 18 07:03 PM
TEISSEYRE THOMASChief Operating OfficerNov 18 '24Sale0.852,8002,38088,227Nov 18 05:41 PM
TEISSEYRE THOMASChief Operating OfficerAug 16 '24Sale1.052,7462,88391,027Aug 16 05:04 PM
PFAI - Pinnacle Food Group Ltd - Stock Price Chart
TickerPFAI [NASD]
CompanyPinnacle Food Group Ltd
CountryCanada
IndustryFarm Products
Market Cap21.12MEPS (ttm)0.07
P/E24.39EPS this Y545.80%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.82EPS next 5Y-
P/B-EPS Q/Q-700.00%
Dividend-Sales Q/Q300.00%
Insider Own69.00%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.11%Earnings-
Analyst Recom-Target Price-
Avg Volume108.19K52W Range1.55 - 4.40
Pinnacle Food Group Limited provides smart farming solutions for vertical and hydroponic farming. It manufactures and sells hydroponic growing systems, which includes sensors, growing trays, racks for growing trays, growing baskets, light panels, and water tanks; and consumables supplies, such as agricultural seeds, grow sponges, plastic planting baskets, and nutrient solutions, as well as technical and consultation support services to individual households and community groups for urban farming. The company also provides advisory, agricultural data intelligence, controllable data applications that assist users to manage growing conditions, environmental design consulting, equipment installation, and agricultural technical supports. It sells its products through distributors in Canada and New ZealandPinnacle Food Group Limited was founded in 2015 and is based in Vancouver, Canada.
PROK - ProKidney Corp - Stock Price Chart
TickerPROK [NASD]
CompanyProKidney Corp
CountryUSA
IndustryBiotechnology
Market Cap922.03MEPS (ttm)-0.60
P/E-EPS this Y10.31%
Forward P/E-EPS next Y-9.51%
PEG-EPS past 5Y-
P/S2974.28EPS next 5Y-4.46%
P/B-EPS Q/Q16.70%
Dividend-Sales Q/Q-
Insider Own27.21%Inst Own40.37%
Insider Trans2.81%Inst Trans-3.69%
Short Float14.44%EarningsMay 12/a
Analyst Recom2.29Target Price5.60
Avg Volume12.78M52W Range0.46 - 7.13
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Darin J.Chief Regulatory OfficerJul 08 '25Sale3.02103,480312,5100Jul 09 04:28 PM
DARIN J WEBEROfficerJul 08 '25Proposed Sale0.61103,48062,761Jul 08 04:20 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Apr 22 '25Buy0.71387,393276,36673,842,723Apr 24 04:15 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Apr 17 '25Buy0.7525,00018,69073,455,330Apr 21 04:37 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Apr 16 '25Buy0.75100,00074,82073,430,330Apr 18 04:15 PM
123456789101120